Benzimidazoles

US7470702B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Wolfgang Staehle · Ingelheim am Rhein, DE
• Hans-Peter Buchstaller · Griesheim, DE
• Alfred Jonczyk · Darmstadt, DE
• Wilfried Rautenberg · Reinheim, DE

Key dates

• Filing date: Oct 14, 2004
• Grant date: Dec 30, 2008
• Expiry date: Oct 14, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D409/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel compounds of the formula I in which R1, R1′, L, E, G, M, Q, U, R2, m, p and q have the meanings indicated. Further, the compounds of formula I can be used as, for example, inhibitors of tyrosine kinases, for example TIE-2 , and can be employed, for example, for the treatment of tumours or other diseases.